SCHEMBL25545980

SCHEMBL25545980

COCCOc1ccc(-c2nc(Cl)sc2CC(C)(C)C)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AAK1 Q2M2I8 5/20 0.35
HTR2C P28335 2/20 0.35
HTR2B P41595 1/20 0.35
S1PR4 O95977 3/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
S1PR5 Q9H228 1/20 0.35
EGFR P00533 6/20 0.33
BTK Q06187 1/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPK1 P28482 1/20 0.32
TLR9 Q9NR96 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25553879 0.88 PTGS1 (0.43) ALDH1A1HPGDHTTSMN1; SMN2AAK1
SCHEMBL25545564 0.88 S1PR4 (0.35) ALDH1A1HPGDHTTSMN1; SMN2AAK1
SCHEMBL25546014 0.87 ALDH1A1 (0.40) ALDH1A1HPGDHTTSMN1; SMN2HTR2C
SCHEMBL25545560 0.86 HTT (0.40) ALDH1A1HTTSMN1; SMN2HTR2CHTR2B
SCHEMBL25545528 0.85 FBP1 (0.43) ALDH1A1HPGDHTTSMN1; SMN2AAK1
SCHEMBL25555900 0.84 EGFR (0.37) AAK1S1PR4S1PR1S1PR3S1PR5
SCHEMBL25545968 0.83 CETP (0.38) PTGS1PTGS2TLR7
SCHEMBL25545990 0.83 FBP1 (0.42) ALDH1A1HPGDHTTSMN1; SMN2AAK1
SCHEMBL25545547 0.83 AAK1 (0.36) ALDH1A1HPGDHTTSMN1; SMN2AAK1
SCHEMBL25545936 0.81 PAX8 (0.39) ALDH1A1EGFRPTGS2KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103368-A EIF4E inhibitors and uses thereof 皮克医疗公司 2024-05-28 CN disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 ALDH1A1 4776/4885HPGD 4535/4885HTT 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.